Gr. Kaufmann et Da. Cooper, Antiretroviral therapy of HIV-1 infection: established treatment strategies and new therapeutic options, CURR OPIN M, 3(5), 2000, pp. 508-514
Recently, studies have shown that non-nucleoside reverse transcriptase inhi
bitors, such as efavirenz or nevirapine, in combination with two nucleoside
analogues have an antiretroviral potency comparable to protease inhibitor
containing regimens. Triple combination therapy that includes a non-nucleos
ide reverse transcriptase inhibitor can therefore be regarded as an effecti
ve alternative first-line treatment of HIV-1 infection.